18 results
424B5
SLGL
Sol-Gel Technologies Ltd
19 Apr 22
Prospectus supplement for primary offering
4:02pm
agents;
to or through one or more underwriters on a firm commitment or agency basis;
through put or call option transactions relating
F-3
v17u7c 5nhs99
7 Apr 22
Shelf registration (foreign)
5:30pm
6-K
EX-99.1
ru9559u
8 Nov 21
Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner
4:55pm
6-K
EX-99.1
sbi2yhzdtxk bh
27 Jul 21
TWYNEO®, a once-daily cream treatment for acne vulgaris, is the first FDA‑approved fixed‑dose combination of tretinoin and benzoyl peroxide
10:39am
6-K
EX-99.1
qdbh 7m0k
28 Jun 21
Sol-Gel Technologies and Galderma announce exclusive licenses for the About Papulopustular Rosacea
8:14am
6-K
EX-99.1
uifvp5zsn7x buznagm
6 Mar 20
Current report (foreign)
6:02am
424B5
2j6h95u1gf
13 Feb 20
Prospectus supplement for primary offering
9:57pm
424B5
yz7qnvp77xces
10 Jan 20
Prospectus supplement for primary offering
5:06pm
424B5
ynso8xswx9ac
31 May 19
Prospectus supplement for primary offering
5:23pm
F-3/A
r71lu8q9fvq
10 Apr 19
Shelf registration (foreign) (amended)
11:46am
F-3
j8sojpx 0lb
28 Mar 19
Shelf registration (foreign)
1:21pm
- Prev
- 1
- Next